Skip to main content
Tech.euFundingExplorerBeta

One Biosciences

a precision oncology biotech company pioneering clinical grade single-cell tumour profiling

Total raised
€15M
€15,000,000
Funding rounds
1
Investors
8
distinct backers
Active since
2025-07
latest 2025-07

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood49
base rate 44% for Series A
  • In typical raise window
  • Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2025-07-17Series A€15MAdamed Technology,Blast,Galion.exe,Invus,Kima Ventures,Polytechnique Ventures+2 moreView deal →

Related news

Similar companies

same sector or country